Marshall Urist

EVP, Research & Investments, Royalty Pharma plc

Bought, 12 months

$0.0M

Sold, 12 months

$12.5M

Companies

Latest trade

Oct 5, 2026

Companies

Royalty Pharma plcEVP, Research & Investments −$12.5M

Trades

RPRX Sold 4,126 shares at $57.10 · planned $0.2M Oct 5

RPRX Sold 4,126 shares at $57.88 · planned $0.2M Sep 28

RPRX Sold 9,099 shares at $55.88 · planned $0.5M Jul 1

RPRX Sold 9,098 shares at $55.18 · planned $0.5M Jun 24

RPRX Sold 13,684 shares at $52.75 · planned $0.7M May 20

RPRX Sold 13,684 shares at $53.06 · planned $0.7M May 14

RPRX Sold 20,000 shares at $41.09 · planned $0.8M Jan 30

RPRX Sold 20,000 shares at $40.26 · planned $0.8M Jan 23

RPRX Sold 20,000 shares at $39.52 · planned $0.8M Jan 16

RPRX Sold 20,000 shares at $40.78 · planned $0.8M Jan 9

RPRX Sold 20,000 shares at $38.48 · planned $0.8M Jan 2

RPRX Sold 20,000 shares at $39.32 · planned $0.8M Dec 26

RPRX Sold 20,000 shares at $38.38 · planned $0.8M Dec 19

RPRX Sold 20,000 shares at $38.32 · planned $0.8M Dec 16

RPRX Sold 41,576 shares at $39.15 · planned $1.6M Dec 5

RPRX Sold 41,575 shares at $39.92 · planned $1.7M Dec 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.